• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000-2010 年加泰罗尼亚(西班牙)结直肠癌筛查的假阳性结果。

False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

机构信息

Cancer Prevention and Control Group, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.

出版信息

J Med Screen. 2012 Jun;19(2):77-82. doi: 10.1258/jms.2012.012013. Epub 2012 May 31.

DOI:10.1258/jms.2012.012013
PMID:22653571
Abstract

OBJECTIVE

To identify factors associated with a false-positive result in a population-based colorectal cancer (CRC) screening programme with the faecal occult blood test (FOBT) in Catalonia between 2000 and 2010.

METHODS

The study population consisted of participants of the Catalan CRC screening programme with a positive FOBT who underwent a colonoscopy for diagnostic confirmation from 2000 to 2010. A false-positive result was defined as having a positive test but detecting no high-risk adenoma or cancer in the follow-up colonoscopy. Multivariate logistic regression models were performed to identify sociodemographic and screening variables related to false-positive results. Adjusted odds ratios (OR) and their 95% confidence intervals (CI) were estimated.

RESULTS

Over the screening period, 1074 (1.7%) of the 63,332 screening tests had a positive result in the Catalan CRC screening programme. The false-positive proportion was 55.2% (n = 546). Women were more likely to have a positive FOBT in the absence of CRC neoplasia than men (adjusted OR = 2.91; 95% CI: 2.22-3.28). During the first prevalence round, the proportion of false-positive results was higher than in subsequent rounds (69.5% vs. 48.9%; P < 0.05). Re-screening and having a bleeding pathology such as haemorrhoids or anal fissures were also associated with a false-positive result.

CONCLUSION

The proportion of false-positive results and the associated risks should be estimated to provide an eligible population with more reliable information on the adverse effects of screening.

摘要

目的

在 2000 年至 2010 年期间,通过在加泰罗尼亚进行基于人群的粪便潜血试验(FOBT)的结直肠癌(CRC)筛查计划,确定与假阳性结果相关的因素。

方法

研究人群包括 2000 年至 2010 年期间参加加泰罗尼亚 CRC 筛查计划且 FOBT 阳性的参与者,他们接受了结肠镜检查以进行诊断确认。假阳性结果定义为检测呈阳性但在后续结肠镜检查中未发现高危腺瘤或癌症。进行多变量逻辑回归模型以确定与假阳性结果相关的社会人口统计学和筛查变量。估计调整后的优势比(OR)及其 95%置信区间(CI)。

结果

在筛查期间,63332 次筛查测试中有 1074 次(1.7%)在加泰罗尼亚 CRC 筛查计划中呈阳性。假阳性比例为 55.2%(n = 546)。与男性相比,女性在没有 CRC 肿瘤的情况下更有可能进行 FOBT 检测呈阳性(调整后的 OR = 2.91;95%CI:2.22-3.28)。在首次患病率轮次中,假阳性结果的比例高于随后的轮次(69.5%比 48.9%;P <0.05)。重新筛查以及存在痔疮或肛裂等出血性病理学也与假阳性结果相关。

结论

应估计假阳性结果的比例和相关风险,以为合格人群提供有关筛查不良影响的更可靠信息。

相似文献

1
False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.2000-2010 年加泰罗尼亚(西班牙)结直肠癌筛查的假阳性结果。
J Med Screen. 2012 Jun;19(2):77-82. doi: 10.1258/jms.2012.012013. Epub 2012 May 31.
2
Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.将家族风险评估添加到粪便潜血试验中可以提高基于人群的结直肠癌筛查的效果。
Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28.
3
Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).从西班牙加泰罗尼亚一项基于人群的结直肠癌筛查试点项目中吸取的经验教训。
J Med Screen. 2007;14(2):81-6. doi: 10.1258/096914107781261936.
4
Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.西班牙加泰罗尼亚地区采用粪便潜血试验进行结直肠癌的重复筛查。
Eur J Cancer Prev. 2012 Jan;21(1):42-5. doi: 10.1097/CEJ.0b013e32834a7e9b.
5
Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.在使用粪便免疫化学检测进行结直肠癌筛查时出现假阳性结果的处方药。
Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub 2016 Jun 21.
6
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
7
Early detection of colorectal cancer with faecal occult blood test screening.粪便潜血试验筛查结直肠癌的早期检测。
Br J Surg. 2010 Oct;97(10):1567-71. doi: 10.1002/bjs.7150.
8
The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.在结直肠癌筛查方面,公众更喜欢粪便潜血试验而非结肠镜检查。
Eur J Cancer Prev. 2008 Oct;17(5):430-7. doi: 10.1097/CEJ.0b013e328305a0fa.
9
Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.采用高敏免疫化学粪便隐血试验筛查家族性结直肠癌:一项初步研究。
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.
10
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.免疫化学粪便潜血试验对近端和远端进展期肿瘤同样敏感。
Am J Gastroenterol. 2012 Oct;107(10):1570-8. doi: 10.1038/ajg.2012.249. Epub 2012 Jul 31.

引用本文的文献

1
Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer.肠道微生物组在结直肠癌诊断和治疗中的开发利用的最新进展。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20204113.
2
Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.在常规筛查中,十种胃肠道和其他医疗条件与粪便潜血检测呈阳性的关联:一项针对英格兰女性的大型前瞻性研究。
Int J Epidemiol. 2019 Apr 1;48(2):549-558. doi: 10.1093/ije/dyy271.
3
Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy in a Colorectal Cancer Screening Program.
非甾体抗炎药诱导的结直肠筛查计划中的结直肠病变。
Med Princ Pract. 2019;28(2):193-195. doi: 10.1159/000494839. Epub 2018 Oct 25.
4
Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?使用粪便免疫化学检测的基于人群的结直肠癌筛查项目:粪便血红蛋白临界值应因年龄和性别而异吗?
BMC Cancer. 2017 Aug 29;17(1):577. doi: 10.1186/s12885-017-3555-3.
5
Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).西班牙的结直肠癌筛查计划:五轮(2000 - 2012年)后关键绩效指标的结果
Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532.
6
Colorectal cancer: from prevention to personalized medicine.结直肠癌:从预防到个性化医疗
World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786.
7
Do current cancer follow-up care practices meet the needs of young adult cancer survivors in Canada? A qualitative inquiry.当前的癌症随访护理实践是否满足加拿大年轻成年癌症幸存者的需求?一项定性研究。
Curr Oncol. 2013 Feb;20(1):14-22. doi: 10.3747/co.20.1207.
8
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).克罗地亚国家结直肠癌筛查计划的结果(2007-2011 年)。
World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.